Home › Companies › TG THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and TG THERAPEUTICS INC.’s Form 8-K, filed 2024-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore TG THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are TG THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Michael S. Weiss | 57,264,472 | -- | -- | 18,849,954 | 34,960,603 | Majority: yes |
| Elect Director: Laurence N. Charney | 57,758,626 | -- | -- | 18,355,800 | 34,960,603 | Majority: yes |
| Elect Director: Yann Echelard | 35,052,596 | -- | -- | 41,061,830 | 34,960,603 | Plurality election |
| Elect Director: Kenneth Hoberman | 52,058,723 | -- | -- | 24,055,703 | 34,960,603 | Majority: yes |
| Elect Director: Daniel Hume | 35,036,823 | -- | -- | 41,077,603 | 34,960,603 | Plurality election |
| Elect Director: Sagar Lonial, MD | 33,299,870 | -- | -- | 42,814,556 | 34,960,603 | Plurality election |
| Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was as follows: | 110,028,319 | 657,578 | 389,132 | -- | -- | Majority: yes |
| Proposal 3 The advisory vote to approve the compensation of the Company's named executive officers was as follows: | 42,346,581 | 31,019,084 | 2,748,761 | -- | 34,960,603 | Majority: yes |
| Proposal 5 The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit was as follows: | 66,744,142 | 8,625,685 | 744,599 | -- | 34,960,603 | Majority: yes |
Source: TG THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-17 — read the filing on EDGAR.
Each item below shows how the 243 asset managers that disclosed a TG THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TG THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 3 The advisory vote to approve the compensation of the Company's named executive officers was as follows:”): 42,346,581 for, 31,019,084 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 154,565,743 outstanding shares: 27% for, 20% against (47.5% of the company cast a for/against vote).
The 240 asset managers below cast 42% of the shares they voted on this item FOR (22,275,777 for, 30,768,915 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,539,276 | 3,066,304 | 0 | 0 | For |
| State Street | 5,650,839 | 69,528 | 0 | 0 | For |
| BlackRock | 65,922 | 4,604,755 | 0 | 0 | Against |
| Wellington | 0 | 3,119,376 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 2,994,139 | 0 | 0 | Against |
| Charles Schwab | 0 | 2,297,220 | 0 | 0 | Against |
| Opaleye Management Inc. | 0 | 0 | 1,830,000 | 0 | Abstain |
| Nuveen | 0 | 1,225,330 | 0 | 0 | Against |
| TIAA | 0 | 1,217,287 | 0 | 0 | Against |
| Fidelity | 298,978 | 873,420 | 0 | 0 | Against |
| Woodline Partners LP | 1,151,525 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 0 | 935,993 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 885,427 | 0 | 0 | Against |
| 683 Capital Management, LLC | 0 | 785,658 | 0 | 0 | Against |
| Northern Trust | 0 | 746,584 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 0 | 718,814 | 0 | 0 | Against |
| Hood River Capital Management LLC | 0 | 615,576 | 0 | 0 | Against |
| Point72 | 0 | 407,194 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 399,120 | 0 | 0 | Against |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 376,682 | 0 | 0 | Against |
| Equitable | 0 | 374,322 | 0 | 0 | Against |
| Goldman Sachs | 793 | 373,368 | 0 | 0 | Against |
| Soleus Capital Management, L.P. | 360,879 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 301,832 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 280,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 240 asset managers. See all 240 in the interactive database.
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 5 The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit was as follows:”): 66,744,142 for, 8,625,685 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 154,565,743 outstanding shares: 43% for, 6% against (48.8% of the company cast a for/against vote).
The 60 asset managers below cast 99.9% of the shares they voted on this item FOR (25,126,679 for, 22,899 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,622,688 | 273 | 0 | 0 | For |
| TIAA | 1,217,287 | 0 | 0 | 0 | For |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 955,712 | 0 | 0 | 0 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 374,322 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 280,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,050 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 175,509 | 0 | 0 | 0 | For |
| First Trust | 157,249 | 0 | 0 | 0 | For |
| Goldman Sachs | 145,974 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 101,760 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 71,446 | 0 | 0 | 0 | For |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 60,516 | 0 | 0 | 0 | For |
| John Hancock | 50,793 | 0 | 0 | 0 | For |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 46,996 | 0 | 0 | 0 | For |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 3 wordings of this item as funds reported it.
90% fund support · no official result
The 56 asset managers below cast 90% of the shares they voted on this item FOR (22,412,799 for, 2,463,299 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,620,598 | 2,363 | 0 | 0 | For |
| TIAA | 1,217,287 | 0 | 0 | 0 | For |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 879,790 | 75,922 | 0 | 0 | For |
| BlackRock | 0 | 877,944 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 374,322 | 0 | 0 | Against |
| Lincoln Financial | 116,000 | 61,050 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 175,509 | 0 | 0 | Against |
| First Trust | 0 | 157,249 | 0 | 0 | Against |
| Goldman Sachs | 145,974 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 127,185 | 0 | 0 | Against |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 0 | 101,760 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 71,446 | 0 | 0 | Against |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 60,516 | 0 | 0 | Against |
| John Hancock | 0 | 50,793 | 0 | 0 | Against |
| Pacific Life | 0 | 47,089 | 0 | 0 | Against |
| JPMorgan | 0 | 46,996 | 0 | 0 | Against |
| Voya | 0 | 45,536 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 30,412 | 0 | 0 | Against |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,853 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was as follows:”): 110,028,319 for, 657,578 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 154,565,743 outstanding shares: 71% for, 0.5% against (72% of the company cast a for/against vote).
The 56 asset managers below cast 100% of the shares they voted on this item FOR (24,862,478 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,622,961 | 0 | 0 | 0 | For |
| TIAA | 1,217,287 | 0 | 0 | 0 | For |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 955,712 | 0 | 0 | 0 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 374,322 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,050 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 175,509 | 0 | 0 | 0 | For |
| First Trust | 157,249 | 0 | 0 | 0 | For |
| Goldman Sachs | 145,974 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 101,760 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 71,446 | 0 | 0 | 0 | For |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 60,516 | 0 | 0 | 0 | For |
| John Hancock | 50,793 | 0 | 0 | 0 | For |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 46,996 | 0 | 0 | 0 | For |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,853 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 3 wordings of this item as funds reported it.
46.0% Plurality election · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel Hume”): 35,036,823 for, 41,077,603 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 154,565,743 outstanding shares: 23% for, 27% withheld (49.2% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (4,638,977 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,066,304 | 0 | 13,143,664 | 0 | Abstain |
| State Street | 1,768 | 0 | 1,621,193 | 0 | Abstain |
| TIAA | 0 | 0 | 1,217,287 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,148,610 | 0 | Abstain |
| Fidelity | 750,986 | 0 | 204,726 | 0 | For |
| BlackRock | 0 | 0 | 877,944 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 374,322 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 177,050 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 175,509 | 0 | Abstain |
| First Trust | 0 | 0 | 157,249 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 145,974 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 127,185 | 0 | Abstain |
| SEI | 0 | 0 | 110,717 | 0 | Abstain |
| ProShares | 0 | 0 | 101,760 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 71,446 | 0 | Abstain |
| Global X | 0 | 0 | 63,047 | 0 | Abstain |
| Guggenheim | 0 | 0 | 60,516 | 0 | Abstain |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 47,089 | 0 | Abstain |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 30,412 | 0 | Abstain |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 27,853 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 52,058,723 for, 24,055,703 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 154,565,743 outstanding shares: 34% for, 16% withheld (49.2% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (19,671,625 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,620,598 | 0 | 2,363 | 0 | For |
| TIAA | 0 | 0 | 1,217,287 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,148,610 | 0 | Abstain |
| Fidelity | 879,790 | 0 | 75,922 | 0 | For |
| BlackRock | 0 | 0 | 877,944 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 374,322 | 0 | Abstain |
| Lincoln Financial | 116,000 | 0 | 61,050 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 175,509 | 0 | Abstain |
| First Trust | 0 | 0 | 157,249 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 145,974 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 127,185 | 0 | Abstain |
| SEI | 0 | 0 | 110,717 | 0 | Abstain |
| ProShares | 0 | 0 | 101,760 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 71,446 | 0 | Abstain |
| Global X | 0 | 0 | 63,047 | 0 | Abstain |
| Guggenheim | 0 | 0 | 60,516 | 0 | Abstain |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 47,089 | 0 | Abstain |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 30,412 | 0 | Abstain |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 27,853 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laurence N. Charney”): 57,758,626 for, 18,355,800 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 154,565,743 outstanding shares: 37% for, 12% withheld (49.2% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (21,075,399 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,620,598 | 0 | 2,363 | 0 | For |
| TIAA | 0 | 0 | 1,217,287 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,148,610 | 0 | Abstain |
| Fidelity | 953,572 | 0 | 2,140 | 0 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 213,402 | 0 | 160,920 | 0 | For |
| Lincoln Financial | 116,000 | 0 | 61,050 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 175,509 | 0 | Abstain |
| First Trust | 0 | 0 | 157,249 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 145,974 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 110,717 | 0 | Abstain |
| ProShares | 0 | 0 | 101,760 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 71,446 | 0 | Abstain |
| Global X | 0 | 0 | 63,047 | 0 | Abstain |
| Guggenheim | 0 | 0 | 60,516 | 0 | Abstain |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 27,853 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael S. Weiss”): 57,264,472 for, 18,849,954 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 154,565,743 outstanding shares: 37% for, 12% withheld (49.2% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (20,683,032 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,768 | 0 | 1,621,193 | 0 | Abstain |
| TIAA | 0 | 0 | 1,217,287 | 0 | Abstain |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 953,572 | 0 | 2,140 | 0 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 213,402 | 0 | 160,920 | 0 | For |
| Lincoln Financial | 0 | 0 | 177,050 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 175,509 | 0 | Abstain |
| First Trust | 0 | 0 | 157,249 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 145,974 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 101,760 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 71,446 | 0 | Abstain |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 60,516 | 0 | Abstain |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 46,996 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 45,536 | 0 | Abstain |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 27,853 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
44% Plurality election · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 33,299,870 for, 42,814,556 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 154,565,743 outstanding shares: 22% for, 28% withheld (49.2% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (3,971,258 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,066,304 | 0 | 13,143,664 | 0 | Abstain |
| State Street | 1,768 | 0 | 1,621,193 | 0 | Abstain |
| TIAA | 0 | 0 | 1,217,287 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,148,610 | 0 | Abstain |
| Fidelity | 128,804 | 0 | 826,908 | 0 | Abstain |
| BlackRock | 0 | 0 | 877,944 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 374,322 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 177,050 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 175,509 | 0 | Abstain |
| First Trust | 0 | 0 | 157,249 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 145,974 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 127,185 | 0 | Abstain |
| SEI | 0 | 0 | 110,717 | 0 | Abstain |
| ProShares | 0 | 0 | 101,760 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 71,446 | 0 | Abstain |
| Global X | 0 | 0 | 63,047 | 0 | Abstain |
| Guggenheim | 0 | 0 | 60,516 | 0 | Abstain |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 47,089 | 0 | Abstain |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 0 | 0 | 45,536 | 0 | Abstain |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 30,412 | 0 | Abstain |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 27,853 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Combines 3 wordings of this item as funds reported it.
46.1% Plurality election · of votes cast
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yann Echelard”): 35,052,596 for, 41,061,830 withheld, per its Form 8-K filed 2024-06-17 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 154,565,743 outstanding shares: 23% for, 27% withheld (49.2% of the company cast a for/withheld vote).
The 55 asset managers below cast 100% of the shares they voted on this item FOR (4,638,484 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,066,304 | 0 | 13,143,664 | 0 | Abstain |
| State Street | 1,768 | 0 | 1,621,193 | 0 | Abstain |
| TIAA | 0 | 0 | 1,217,287 | 0 | Abstain |
| Charles Schwab | 0 | 0 | 1,148,610 | 0 | Abstain |
| Fidelity | 750,986 | 0 | 204,726 | 0 | For |
| BlackRock | 0 | 0 | 877,944 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 374,322 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 177,050 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 175,509 | 0 | Abstain |
| First Trust | 0 | 0 | 157,249 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 145,974 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 127,185 | 0 | Abstain |
| SEI | 0 | 0 | 110,717 | 0 | Abstain |
| ProShares | 0 | 0 | 101,760 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 71,446 | 0 | Abstain |
| Global X | 0 | 0 | 63,047 | 0 | Abstain |
| Guggenheim | 0 | 0 | 60,516 | 0 | Abstain |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 47,089 | 0 | Abstain |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 30,412 | 0 | Abstain |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 27,853 | 0 | Abstain |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Ranked by the number of TG THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 154,565,743 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.74% |
| 2 | State Street | 3.70% |
| 3 | BlackRock | 3.02% |
| 4 | Wellington | 2.02% |
| 5 | PICTET ASSET MANAGEMENT SA | 1.94% |
| 6 | Charles Schwab | 1.49% |
| 7 | Opaleye Management Inc. | 1.18% |
| 8 | Nuveen | 0.79% |
| 9 | TIAA | 0.79% |
| 10 | Fidelity | 0.76% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 13.78% | 13F |
| Vanguard Group | 10.04% | 13F |
| State Street | 5.04% | 13F |
| Millennium Management | 2.29% | 13F |
| Wellington Management | 2.04% | 13F |
| Geode Capital | 2.01% | 13F |
| Citadel Advisors | 1.58% | 13F |
| Nuveen | 1.01% | 13F |
| Goldman Sachs | 0.98% | 13F |
| Northern Trust | 0.84% | 13F |
Percentages above are of 154,565,743 shares outstanding, as reported by TG THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At TG THERAPEUTICS INC.'s shareholder meeting held 2024-06-14, in the 2023-2024 proxy season, 243 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,979 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 58% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-17.
TG THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.